LPL and hypertriglyceridemia: Removal of LPL by Cre during skeletal and cardiac muscle development does not mimic LPL deficiencies in human patients, however, the mouse provides an improved system than those previously available for testing alternative gene therapies to reduce hypertriglyceridemia associated with LPL deficiency.